Back
ca199 | 25423

CA19-9

Keywords:
Cancer
Malignoma
Pancreas
Tumor
Tumor marker
ca199
gastrointestinal
ovary

Status

Material
Serum Serum gel tube, golden (1)
Hint

No measurable CA 19-9 increases are expected in patients with the rare Lewis a-b- blood group (in 3-7% of the population), as they lack a sialyltransferase important for CA 19-9 epitope expression and a fucosylated precursor chain.

Min. volume 500 µL
Stability
Stability
2 days / 2-8°C
3 months / -20°C
Duration 2 hours
Frequency 6 x per week
Method Chemiluminescent Immuno Assay

Price/Rate

Price
Price
CHF 21.60
Rate
Rate
21.60 TP